Novozymes A/S

BMV:NSIS N Stock Report

Market Cap: Mex$419.7b

Novozymes Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ester Baiget

Chief executive officer

DKK 29.1m

Total compensation

CEO salary percentage33.33%
CEO tenure4.2yrs
CEO ownershipn/a
Management average tenure1.7yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ester Baiget's remuneration changed compared to Novozymes's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023DKK 29mDKK 10m

DKK 3b

Sep 30 2023n/an/a

DKK 3b

Jun 30 2023n/an/a

DKK 3b

Mar 31 2023n/an/a

DKK 4b

Dec 31 2022DKK 24mDKK 10m

DKK 4b

Sep 30 2022n/an/a

DKK 3b

Jun 30 2022n/an/a

DKK 3b

Mar 31 2022n/an/a

DKK 3b

Dec 31 2021DKK 24mDKK 8m

DKK 3b

Sep 30 2021n/an/a

DKK 3b

Jun 30 2021n/an/a

DKK 3b

Mar 31 2021n/an/a

DKK 3b

Dec 31 2020DKK 24mDKK 7m

DKK 3b

Compensation vs Market: Ester's total compensation ($USD4.24M) is about average for companies of similar size in the MX market ($USD5.82M).

Compensation vs Earnings: Ester's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Ester Baiget (52 yo)

4.2yrs
Tenure
DKK 29,100,000
Compensation

Ms. Ester Baiget serves as Chief Executive Officer and President of Novozymes A/S since joining on February 1, 2020. She serves as Member of Supervisory Board at Akzo Nobel N.V. since 2022. She served as t...

Leadership Team

NamePositionTenureCompensationOwnership
Ester Baiget
President & CEO4.2yrsDKK 29.10mno data
Rainer Lehmann
Executive VP & CFOless than a yearDKK 6.40mno data
Anders Lund
Chief Operating Officerless than a yearDKK 7.70mno data
Claus Fuglsang
Chief Scientific Officer3.6yrsno datano data
Tobias Bjorklund
Head of Investor Relationsno datano datano data
Winnie Bugel
General Counsel of Legalless than a yearno datano data
Tue Micheelsen
Vice President of Global Sales & Marketingno datano datano data
Morten Rasmussen
Executive Vice President of People & Stakeholder Relations3yrsno datano data
Tina Fano
Executive Vice President of Planetary Health Biosolutions8.2yrsDKK 7.60mno data
Amy Byrick
Executive Vice President of Human Health Biosolutions3yrsno datano data
Henrik Nielsen
Executive Vice President of Strategy & Integrationless than a yearno datano data
Jacob Paulsen
Executive Vice President of Food & Beverage Biosolutionsless than a yearno datano data
1.7yrs
Average Tenure
49.5yo
Average Age

Experienced Management: NSIS N's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jesper Brandgaard
Vice Chair of the Boardless than a yearno datano data
Cornelis de Jong
Independent Chairman4.2yrsDKK 1.78m0.0011%
MX$ 4.5m
Kim Stratton
Independent Vice Chair7.2yrsDKK 1.29mno data
Kasim Kutay
Director7.2yrsDKK 803.00k0.00023%
MX$ 965.4k
Heine Dalsgaard
Director4.2yrsDKK 1.07m0.00065%
MX$ 2.7m
Lise Kaae
Directorless than a yearno datano data
Anders Knudsen
Employee Representative Director11.2yrsDKK 535.00kno data
Sharon James
Independent Director4.2yrsDKK 1.07mno data
Anne Breum
Employee Representative Director3.1yrsDKK 535.00k0.00010%
MX$ 419.7k
Preben Nielsen
Employee Representative Director3.1yrsDKK 803.00k0.000090%
MX$ 377.8k
Jens Obro
Employee Representative Director3.1yrsDKK 535.00k0.00012%
MX$ 503.7k
Morten Otto Sommer
Independent Director2.1yrsDKK 1.03m0.00022%
MX$ 923.4k
3.6yrs
Average Tenure
59yo
Average Age

Experienced Board: NSIS N's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/10 09:49
End of Day Share Price 2024/01/12 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Novozymes A/S is covered by 27 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexander SloaneBarclays
Cezara LozneanuBarclays
Sebastian SatzBarclays